Rating History for Eli Lilly (LLY) by BMO Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/6/2026 Evan Seigerman Maintain Outperform
(N/A)
1,400.00
(1,300.00)
 
 
  Details